3-149177867-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000096.4(CP):c.2991T>C(p.His997His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0416 in 1,613,350 control chromosomes in the GnomAD database, including 1,660 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 98 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1562 hom. )
Consequence
CP
NM_000096.4 synonymous
NM_000096.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.990
Publications
10 publications found
Genes affected
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
CP Gene-Disease associations (from GenCC):
- aceruloplasminemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- disorder of iron metabolism and transportInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 3-149177867-A-G is Benign according to our data. Variant chr3-149177867-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0304 (4625/152276) while in subpopulation NFE AF = 0.0441 (2997/68022). AF 95% confidence interval is 0.0427. There are 98 homozygotes in GnomAd4. There are 2290 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 98 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CP | NM_000096.4 | c.2991T>C | p.His997His | synonymous_variant | Exon 17 of 19 | ENST00000264613.11 | NP_000087.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CP | ENST00000264613.11 | c.2991T>C | p.His997His | synonymous_variant | Exon 17 of 19 | 1 | NM_000096.4 | ENSP00000264613.6 |
Frequencies
GnomAD3 genomes AF: 0.0304 AC: 4628AN: 152158Hom.: 99 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4628
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0334 AC: 8405AN: 251326 AF XY: 0.0354 show subpopulations
GnomAD2 exomes
AF:
AC:
8405
AN:
251326
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0428 AC: 62464AN: 1461074Hom.: 1562 Cov.: 31 AF XY: 0.0426 AC XY: 30940AN XY: 726854 show subpopulations
GnomAD4 exome
AF:
AC:
62464
AN:
1461074
Hom.:
Cov.:
31
AF XY:
AC XY:
30940
AN XY:
726854
show subpopulations
African (AFR)
AF:
AC:
277
AN:
33462
American (AMR)
AF:
AC:
715
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
348
AN:
26126
East Asian (EAS)
AF:
AC:
4
AN:
39684
South Asian (SAS)
AF:
AC:
3008
AN:
86246
European-Finnish (FIN)
AF:
AC:
3356
AN:
53412
Middle Eastern (MID)
AF:
AC:
301
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
52357
AN:
1111288
Other (OTH)
AF:
AC:
2098
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2849
5697
8546
11394
14243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1956
3912
5868
7824
9780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0304 AC: 4625AN: 152276Hom.: 98 Cov.: 32 AF XY: 0.0308 AC XY: 2290AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
4625
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
2290
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
401
AN:
41570
American (AMR)
AF:
AC:
307
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
49
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5188
South Asian (SAS)
AF:
AC:
146
AN:
4822
European-Finnish (FIN)
AF:
AC:
651
AN:
10612
Middle Eastern (MID)
AF:
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2997
AN:
68022
Other (OTH)
AF:
AC:
58
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
230
459
689
918
1148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
23
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Nov 06, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Deficiency of ferroxidase Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hermansky-Pudlak syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.